TMCnet News
Research and Markets: Global Influenza Market 2014-2018 - Emergence of Quadrivalent Vaccines for H1N1 InfluenzaDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/ckndml/global_influenza) has announced the addition of the "Global Influenza Market 2014-2018" report to their offering. The Global Influenza market to grow at a CAGR of 8.10 percent over the period 2013-2018 Influenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to severe illness. The disease can be fatal in some cases. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza. One key trend upcoming in this market is the emergence of quadrivalent vaccines for H1N1 influenza, which confer additional protection compared to trivalent vaccines. According to the report, increase in awareness regarding influenza is one of the major drivers of the market. Lack of awareness regarding the infection, its implications, and available vaccines increases the chances of developing the infection. Further, the report states that one of the main challenges in the market is the antigenic drift in influenza vaccines. Antigenic drift necessitates the reformulation of existing vaccines in order to sustain the efficacy of these vaccines against circulating viral strains. To calculate the market size, the report considers the revenue generated through the sales of various vaccines and drugs administered to prevent and treat human infection caused by influenza virus. Key Vendors
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/ckndml/global_influenza
|